Though the findings of the FDA advisory panel are nonbinding, the FDA usually sides with the panel, which may lead to oral phenylephrine products being removed from store shelves in the near future
News on the Net -- New York Post, Bio and Archives--September 12, 2023
| Comments | Reader Friendly | Subscribe | Email Us
An advisory panel of the Food and Drug Administration stated today that virtually all over-the-counter decongestants simply don’t work.
The FDA panel found that phenylephrine — the active ingredient in
Sudafed, Benadryl, Robitussin and other popular decongestants — is
nearly useless at reducing nasal congestion. ---More...
View Comments
News from around the world